Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia.Peter Bross, Richard Pazdur, Eamon Duffy et al.|PubMed|2001Cited by 861
Velcade®: U.S. FDA Approval for the Treatment of Multiple Myeloma Progressing on Prior TherapyRobert C. Kane, Richard Pazdur, Peter Bross et al.|The Oncologist|2003Cited by 629